tradingkey.logo

Elanco Animal Health Inc

ELAN
View Detailed Chart
22.000USD
-0.850-3.72%
Close 11/03, 16:00ETQuotes delayed by 15 min
10.93BMarket Cap
25.18P/E TTM

Elanco Animal Health Inc

22.000
-0.850-3.72%
Intraday
1m
30m
1h
D
W
M
D

Today

-3.72%

5 Days

-1.21%

1 Month

+6.59%

6 Months

+125.64%

Year to Date

+81.67%

1 Year

+74.60%

View Detailed Chart

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Elanco Animal Health Inc's Score

Industry at a Glance

Industry Ranking
11 / 159
Overall Ranking
29 / 4617
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 15 analysts
Buy
Current Rating
21.909
Target Price
-1.09%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Elanco Animal Health Inc Highlights

StrengthsRisks
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 26.03, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 545.76M shares, decreasing 2.99% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 8.10M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.06.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Elanco Animal Health Inc Info

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Ticker SymbolELAN
CompanyElanco Animal Health Inc
CEOMr. Jeffrey N. (Jeff) Simmons
Websitehttps://www.elanco.com/
KeyAI